ArticleBMC cancer2021

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Narendra V Sankpal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.